Epistemis

Absence or decrease in peripheral arterial pulses

Specialty: Cardiovascular.

  • weak peripheral pulses
  • abolition of distal pulses
  • peripheral hyposphygmia

Why it occurs

  • Atherosclerotic occlusive peripheral artery disease
  • Acute arterial occlusion of embolic or thrombotic origin
  • Acute aortic dissection (with spread and involvement of the main arterial branches)
  • Coarctation of the aorta (femoral-radial decrease or delay)
  • Large vessel vasculitis (such as Takayasu arteritis or giant cell arteritis)
  • Extrinsic arterial compression or popliteal artery entrapment syndrome

Initial workup

Determination and recording of the Ankle-Arm Index (ABI); Arterial Doppler ultrasound of the affected limb to observe vascular permeability and flow wave morphology (loss of the physiological triphasic wave); Whole-body computed tomography angiography (CT-Angio) if aortic dissection or proximal occlusive pathology is suspected; Diagnostic arteriography.

red flags

Sudden absence of a previously documented pulse or marked asymmetry of pulses between homologous extremities, associated with severe acute pain of the extremity, cutaneous cadaverous pallor, coldness of clear proximal delimitation, paresthesias of dermatomal distribution, weakness or paralysis of the distal muscle groups, or chest pain of sudden onset and tearing of interscapular location (suggestive of aortic dissection). Requires immediate vascular surgical bypass to rule out aortic catastrophe or acute ischemia.

Standard management

  • Unfractionated heparin — immediately indicated in suspected acute arterial occlusion to prevent the spread of the thrombus; intravenous bolus of 80 IU/kg followed by continuous infusion adjusted according to aPTT between 1.5 and 2.5 times the control value
  • Alprostadil — prostaglandin E1, indicated in critical ischemia of non-revascularizable lower limbs to induce vasodilation and microvascular antiaggregation; 40 to 60 mcg as a slow 2-hour intravenous infusion
  • Atorvastatin — statin for the management of underlying atherosclerotic arteriopathy; 40 mg once daily orally
  • Enalapril (to control high blood pressure if it is associated with obstructive vasculopathy, monitoring kidney function; 5 to 10 mg per day orally).

Educational guidance for study. It is NOT a prescription recommendation. The actual choice depends on the cause, the patient, and current guidelines.

Area
Cardiovascular
Listed causes
6
Treatment options
4
Download Epistemis